GB0202213D0 - Methods - Google Patents

Methods

Info

Publication number
GB0202213D0
GB0202213D0 GBGB0202213.5A GB0202213A GB0202213D0 GB 0202213 D0 GB0202213 D0 GB 0202213D0 GB 0202213 A GB0202213 A GB 0202213A GB 0202213 D0 GB0202213 D0 GB 0202213D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0202213.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0202213.5A priority Critical patent/GB0202213D0/en
Publication of GB0202213D0 publication Critical patent/GB0202213D0/en
Priority to AU2003238432A priority patent/AU2003238432A1/en
Priority to PCT/GB2003/000337 priority patent/WO2003064687A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
GBGB0202213.5A 2002-01-31 2002-01-31 Methods Ceased GB0202213D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0202213.5A GB0202213D0 (en) 2002-01-31 2002-01-31 Methods
AU2003238432A AU2003238432A1 (en) 2002-01-31 2003-01-28 Prognostic and treatment methods relating to fibrotic liver disease
PCT/GB2003/000337 WO2003064687A2 (en) 2002-01-31 2003-01-28 Prognostic and treatment methods relating to fibrotic liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0202213.5A GB0202213D0 (en) 2002-01-31 2002-01-31 Methods

Publications (1)

Publication Number Publication Date
GB0202213D0 true GB0202213D0 (en) 2002-03-20

Family

ID=9930101

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0202213.5A Ceased GB0202213D0 (en) 2002-01-31 2002-01-31 Methods

Country Status (3)

Country Link
AU (1) AU2003238432A1 (en)
GB (1) GB0202213D0 (en)
WO (1) WO2003064687A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010106140A1 (en) 2009-03-19 2010-09-23 Universite D'angers Non-invasive method for assessing liver fibrosis progression
DE102011017208A1 (en) * 2011-04-15 2012-10-18 Johann Wolfgang Goethe-Universität Bivalirudin and other hirudin analogs for preserving cellular functionality in clinical cell therapy

Also Published As

Publication number Publication date
WO2003064687A3 (en) 2003-11-13
AU2003238432A1 (en) 2003-09-02
WO2003064687A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
DE50309217D1 (en) Benzimidazolderivate
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
DE50303619D1 (en) Reibschweissvorrichtung
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
DE50307787D1 (en) Isophthalsäurederivate
GB0208928D0 (en) Methods
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003264900A8 (en) Cast-cutter
GB0220045D0 (en) Methods
DE50304964D1 (en) Handhobelmaschine
GB0221711D0 (en) Methods
AU2003262681A8 (en) Hemo-aide
DE10392833D2 (en) Geotextilie
GB0219723D0 (en) Methods
GB0204967D0 (en) Methods
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
GB0202213D0 (en) Methods
GB0222276D0 (en) Methods
DE50309021D1 (en) Etherlacton
GB0213579D0 (en) Methods
GB0200526D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)